Rationale Systemic activation of procoagulant and inflammatory mechanisms has been
implicated in the pathogenesis of COVID-19. Knowledge of activation of these host response …

COVID-19, initially regarded as specific lung disease, exhibits an extremely broad spectrum
of symptoms. Extrapulmonary manifestations of the disease also include important …

Severe COVID-19 is characterized by acute respiratory distress syndrome (ARDS)-like
hyperinflammation and endothelial dysfunction, that can lead to respiratory and multi organ …

Novel mechanistic insights are discussed herein that link a single, nontoxic, low-dose
radiotherapy (LDRT) treatment (0.5–1.0 Gy) to (1) beneficial subcellular effects mediated by …

Since the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
spread as a new strain of coronavirus disease (COVID‐19) and progressed as a global …

Background COVID-19 is a type of pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection that was identified in December 2019 …

Abstract Severe coronavirus disease 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is characterized by an unpredictable …

SARS-CoV-2 infection or COVID-19 has become a worldwide pandemic; however, effective
treatment for COVID-19 remains to be established. Along with acute respiratory distress …

Abstract Coronavirus disease 2019 (COVID-19) is associated with irreversible effects on
vital organs, especially the respiratory and cardiac systems. While the immune system plays …

The coronavirus disease 2019 (COVID-19) has become a substantial threat to the
international health sector and the global economy. As of 26 December 2021, the number of …